CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 184 enrolled
Drug / intervention
Vancomycin +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03432858
NCT03432858Phase 4Completed
CompareCT.gov

Endoscopic Carpal Tunnel Release, Infection Incidence, and Prophylactic Antibiotics: Indicated or Kick the Habit?

WellSpan Health·interventional·Posted Feb 14, 2018·Updated Nov 10, 2021

In Brief

A Phase 4 clinical trial evaluating Vancomycin, Cefazolin, and 1 other intervention for Carpal Tunnel Syndrome. Completed, enrolled 184 participants across 1 site.

Detailed Summary

This is a clinical trial to determine how effective antibiotics administered prior to endoscopic carpal tunnel release surgery are in preventing surgical site infections.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCarpal Tunnel Syndrome
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedFeb 14, 2018
Enrollment StartMay 17, 2018
Primary CompletionDec 14, 2020
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 8.4 years ago

Interventions

Vancomycindrug

Vancomycin - 1-gram dosing

Cefazolindrug

2-gram dosing for patients \<120 kg 3-gram dosing for patients 120 kg or greater

Saline Solutiondrug

Placebo